S. Chan

The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2

G. Ball, I. Ellis, R. Rees, 2017, Oncotarget.

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer

G. Ball, I. Ellis, R. Rees, 2014, British Journal of Cancer.